| Characteristic | All, n = 379 (%) | Age, No.(%) | pa | ||
| <20 years, n = 60 (%) | 20 - 40 Years, n = 290 (%) | ≥40 Years, n = 29 (%) | |||
| |
|
|
|
| 0.251 |
| Male | 220 (58.0) | 33 (55.0) | 174 (60.0) | 13 (44.8) |
|
| Female | 159 (42.0) | 27 (45.0) | 116 (40.0) | 16 (55.2) |
|
| |
|
|
|
| 0.014 |
| Extremity | 343 (90.5) | 59 (98.3) | 259 (89.3) | 25 (86.2) |
|
| Pelvis | 24 (6.3) | 1 (1.7) | 21 (7.2) | 2 (6.9) |
|
| Etc. | 12 (3.2) | 0 (0.0) | 10 (3.5) | 2 (6.9) |
|
| |
|
|
|
| 0.009 |
| Localized (meta(−)) | 272 (71.8) | 52 (86.7) | 197 (67.9) | 23 (79.3) |
|
| Metastasis(+) | 107 (28.2) | 8 (13.3) | 93 (32.1) | 6 (20.7) |
|
| |
|
|
|
| 0.003 |
| OB* | 248 (65.4) | 41 (68.3) | 197 (67.9) | 10 (34.5) |
|
| FB† | 54 (14.2) | 7 (11.7) | 39 (13.4) | 8 (27.6) |
|
| CB‡ | 21 (5.5) | 5 (8.3) | 13 (4.5) | 3 (10.3) |
|
| Others | 35 (9.2) | 1 (1.7) | 30 (10.3) | 4 (13.8) |
|
| Unknown | 21 (5.5) | 6 (10.0) | 11 (3.8) | 4 (13.8) |
|
| |
|
|
|
| 0.843 |
| Good Response (Necrosis ≥ 90%) | 155 (40.9) | 24 (40.0) | 120 (41.4) | 11 (37.9) |
|
| Poor Response (Necrosis < 90%) | 224 (59.1) | 36 (60.0) | 170 (58.6) | 18 (62.1) |
|